Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1

Conditions

Pain, Postoperative 2Pain 2Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Agnosia 2Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Follicular 1Lymphoma 1Kidney Neoplasms 1Ileus 1Head and Neck Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Curative Breast Cancer Surgery 1Constipation 1Colonic Neoplasms 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1Acute Pain 1

Interventions

Nivolumab 74Sunitinib 73pembrolizumab 49Everolimus 39Sorafenib 36Bevacizumab 36Axitinib 36cabozantinib 35Radiosurgery 33Ipilimumab 33pazopanib 32Magnetic Resonance Spectroscopy 27Interleukin-2 27aldesleukin 23Specimen Handling 22Cyclophosphamide 21lenvatinib 20fludarabine phosphate 17Radiotherapy 16Interferon-alpha 15Peripheral Blood Stem Cell Transplantation 14Gemcitabine 14Biopsy 14temsirolimus 13Nephrectomy 13durvalumab 11Immunohistochemistry 11CTLA-4 Antigen 11Blood Specimen Collection 11Capecitabine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Renal Cell × Ketorolac Tromethamine × Clear all
NCT04495894 2025-03-04

Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma

Emory University

Phase 2 Terminated
68 enrolled 14 charts
GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell

NCT01836406 2014-02-19

Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy

Yonsei University

Phase NA Completed
16 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡